Endoscopic Lung Volume Reduction: An Expert Panel Recommendation

Respiration

Volumn 91, Issue 3, 2016, Pages 241-250

  Herth, Felix J F ^a,b,g   Slebos, DIrk Jan ^a   Rabe, Klaus F ^c,d   Shah, Pallav L ^e,f  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c Airway Research Center North (ARCN)   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^g UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Bronchoscopy; Chronic obstructive pulmonary disease; Emphysema; Expert statement; Lung volume reduction

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; SURGICAL GLUE;

ABLATION THERAPY; ALGORITHM; ARTICLE; BRONCHOSCOPIC THERMAL VAPOR ABLATION; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL (TOPIC); COMPUTER ASSISTED TOMOGRAPHY; CORTICOSTEROID THERAPY; EMBOLIZATION COIL; HEALTH CARE QUALITY; HOSPITALIZATION; HUMAN; IMMUNIZATION; LUNG EMPHYSEMA; LUNG FUNCTION TEST; LUNG RESECTION; LUNG VOLUME; MEDICAL EXPERT; MEDICAL TECHNOLOGY; MORBIDITY; MULTICENTER STUDY (TOPIC); PATIENT SELECTION; PNEUMOTHORAX; PRIORITY JOURNAL; PULMONARY REHABILITATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING CESSATION; PRACTICE GUIDELINE; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ALGORITHMS; BRONCHOSCOPY; HUMANS; PATIENT SELECTION; PNEUMONECTOMY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

EID: 84959196483     PISSN: 00257931     EISSN: 14230356     Source Type: Journal    
DOI: 10.1159/000444090     Document Type: Article

References (58)

1. Vestbo J, et al: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347-365.
2. Kemp SV, Polkey MI, Shah PL: The epidemiology, etiology, clinical features, and natural history of emphysema. Thorac Surg Clin 2009; 19: 149-158.
3. Klooster K, et al: Determining the role of dynamic hyperinflation in patients with severe chronic obstructive pulmonary disease. Respiration 2015; 90: 306-313.
4. Jordan RE, et al: Case finding for chronic obstructive pulmonary disease: A model for optimising a targeted approach. Thorax 2010; 65: 492-498.
5. Halbert RJ, et al: Global burden of COPD: systematic review and meta-analysis. Eur Respir J 2006; 28: 523-532.
6. Bloom DE, Cafiero ET, Jané-Llopis E, Abrahams-Gessel S, Bloom LR, Fathima S, Feigl AB, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein AZ, Weinstein C: The global economic burden of noncommunicable diseases. World Economic Forum, 2011. http://www.weforum.org/EconomicsOfNCD.
7. Qaseem A, et al: Diagnosis and management of stable chronic obstructive pulmonary disease: A clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155: 179-191.
8. Cooper CB: The connection between chronic obstructive pulmonary disease symptoms and hyperinflation and its impact on exercise and function. Am J Med 2006; 119(suppl 1):21-31.
9. Brantigan OC, Mueller E: Surgical treatment of pulmonary emphysema. Am Surg 1957; 23: 789-804.
10. Marchetti N, Criner GJ: Surgical approaches to treating emphysema: lung volume reduction surgery, bullectomy, and lung transplantation. Semin Respir Crit Care Med 2015; 36: 592-608.
11. Beckers F, et al: Unilateral lobe resection by video-assisted thoracoscopy leads to the most optimal functional improvement in severe emphysema. Thorac Cardiovasc Surg 2014, Epub ahead of print.
12. Pompeo E, et al: Randomized comparison of awake nonresectional versus nonawake resectional lung volume reduction surgery. J Thorac Cardiovasc Surg 2012; 143: 47-54, 54 e1.
13. Criner GJ, et al: The National Emphysema Treatment Trial (NETT). II. Lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med 2011; 184: 881-893.
14. Van Raemdonck D, Ninane V: Lung volume reduction for severe emphysema: do we need a scalpel or a scope? Eur Respir Rev 2010; 19: 242-247.
15. Lynch DA, Newell JD: Quantitative imaging of COPD. J Thorac Imaging 2009; 24: 189-194.
16. Muller NL, et al: 'Density mask'. An objective method to quantitate emphysema using computed tomography. Chest 1988; 94: 782-787.
17. Mets OM, et al: Quantitative computed tomography in COPD: possibilities and limitations. Lung 2012; 190: 133-145.
18. Gevenois PA, et al: Comparison of computed density and macroscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1995; 152: 653-657.
19. Gevenois PA, et al: Comparison of computed density and microscopic morphometry in pulmonary emphysema. Am J Respir Crit Care Med 1996; 154: 187-192.
20. Koenigkam-Santos M, et al: Incomplete fissures in severe emphysematous patients evaluated with MDCT: incidence and interobserver agreement among radiologists and pneumologists. Eur J Radiol 2012; 81: 4161-4166.
21. Toma TP, et al: Bronchoscopic volume reduction with valve implants in patients with severe emphysema. Lancet 2003; 361: 931-933.
22. Sciurba FC, et al: A randomized study of endobronchial valves for advanced emphysema. N Engl J Med 2010; 363: 1233-1244.
23. Herth FJ, et al: Efficacy predictors of lung volume reduction with Zephyr valves in a European cohort. Eur Respir J 2012; 39: 1334-1342.
24. Ninane V, et al: Multicentre European study for the treatment of advanced emphysema with bronchial valves. Eur Respir J 2012; 39: 1319-1325.
25. Valipour A, et al: Target lobe volume reduction and COPD outcome measures after endobronchial valve therapy. Eur Respir J 2014; 43: 387-396.
26. Davey C, et al: Bronchoscopic lung volume reduction with endobronchial valves for patients with heterogeneous emphysema and intact interlobar fissures (the BeLieVeR-HIFi study): A randomised controlled trial. Lancet 2015; 386: 1066-1073.
27. Schuhmann M, et al: Computed tomography predictors of response to endobronchial valve lung reduction treatment. Comparison with Chartis. Am J Respir Crit Care Med 2015; 191: 767-774.
28. Gompelmann D, et al: Predicting atelectasis by assessment of collateral ventilation prior to endobronchial lung volume reduction: A feasibility study. Respiration 2010; 80: 419-425.
29. Herth FJ, et al: Radiological and clinical outcomes of using Chartis to plan endobronchial valve treatment. Eur Respir J 2013; 41: 302-308.
30. Klooster K: Endobronchial valve treatment versus standard medical care in patients with emphysema without interlobar collateral ventilation (The STELVIO-Trial). Am J Respir Crit Care Med 2015; 191:A6312.
31. Gompelmann D, Eberhardt R, Herth F: Endoscopic volume reduction in COPD-A critical review. Dtsch Arztebl Int 2014; 111: 827-833.
32. Gompelmann D, et al: Pneumothorax following endobronchial valve therapy and its impact on clinical outcomes in severe emphysema. Respiration 2014; 87: 485-491.
33. Valipour A, et al: Expert statement: pneumothorax associated with endoscopic valve therapy for emphysema-potential mechanisms, treatment algorithm, and case examples. Respiration 2014; 87: 513-521.
34. Venuta F, et al: Long-term follow-up after bronchoscopic lung volume reduction in patients with emphysema. Eur Respir J 2012; 39: 1084-1089.
35. Hopkinson NS, et al: Atelectasis and survival after bronchoscopic lung volume reduction for COPD. Eur Respir J 2011; 37: 1346-1351.
36. Eberhardt R, et al: Complete unilateral vs partial bilateral endoscopic lung volume reduction in patients with bilateral lung emphysema. Chest 2012; 142: 900-908.
37. Klooster K, Ten Hacken NH, Slebos DJ: The lung volume reduction coil for the treatment of emphysema: A new therapy in development. Expert Rev Med Devices 2014; 11: 481-489.
38. Herth FJ, et al: Bronchoscopic lung volume reduction with a dedicated coil: A clinical pilot study. Ther Adv Respir Dis 2010; 4: 225-231.
39. Slebos DJ, et al: Bronchoscopic lung volume reduction coil treatment of patients with severe heterogeneous emphysema. Chest 2012; 142: 574-582.
40. Shah PL, et al: Endobronchial coils for the treatment of severe emphysema with hyperinflation (RESET): A randomised controlled trial. Lancet Respir Med 2013; 1: 233-240.
41. Deslee G, et al: Lung volume reduction coil treatment for patients with severe emphysema: A European multicentre trial. Thorax 2014; 69: 980-986.
42. Klooster K, et al: Lung volume reduction coil treatment in chronic obstructive pulmonary disease patients with homogeneous emphysema: A prospective feasibility trial. Respiration 2014; 88: 116-125.
43. Deslee G: Lung volume reduction coil treatment improves exercise capacity at 6 months in severe emphysema: preliminary results of the randomized control trial REVOLENS. Am J Respir Crit Care Med 2015; 191:A6364.
44. Snell G, et al: Bronchoscopic thermal vapour ablation therapy in the management of heterogeneous emphysema. Eur Respir J 2012; 39: 1326-1333.
45. Herth FJ, et al: Characterization of outcomes 1 year after endoscopic thermal vapor ablation for patients with heterogeneous emphysema. Int J Chron Obstruct Pulmon Dis 2012; 7: 397-405.
46. Gompelmann D, et al: The localized inflammatory response to bronchoscopic thermal vapor ablation. Respiration 2013; 86: 324-331.
47. Bandyopadhyay S, et al: Segmental approach to lung volume reduction therapy for emphysema patients. Respiration 2015; 89: 76-81.
48. Magnussen H, et al: Effect of fissure integrity on lung volume reduction using a polymer sealant in advanced emphysema. Thorax 2012; 67: 302-308.
49. Herth FJ, et al: Treatment of advanced emphysema with emphysematous lung sealant (AeriSeal ® ). Respiration 2011; 82: 36-45.
50. Kramer MR, et al: Bilateral endoscopic sealant lung volume reduction therapy for advanced emphysema. Chest 2012; 142: 1111-1117.
51. Come CE, et al: A randomised trial of lung sealant versus medical therapy for advanced emphysema. Eur Respir J 2015; 46: 651-662.
52. Fuehner T, et al: Lung transplantation after endoscopic lung volume reduction. Respiration 2015; 90: 243-250.
53. Park TS, Hong Y, Lee JS, Oh SY, Lee SM, Kim N, Seo JB, Oh YM, Lee SD, Lee SW: Bronchoscopic lung volume reduction by endobronchial valve in advanced emphysema: The first Asian report. Int J Chron Obstruct Pulmon Dis 2015; 10: 1501-1511.
54. Szlubowska S, Zalewska-Puchała J, Majda A, Kocoń P, Soja J, Gnass M, Pasko E, Cmiel A, Szlubowski A, Kuzdzał J: The influence of lung volume reduction with intrabronchial valves on the quality of life of patients with heterogeneous emphysema-A prospective study. Pneumonol Alergol Pol 2015; 83: 418-423.
55. Sterman DH, Mehta AC, Wood DE, Mathur PN, McKenna RJ Jr, Ost DE, Truwit JD, Diaz P, Wahidi MM, Cerfolio R, Maxfield R, Musani AI, Gildea T, Sheski F, Machuzak M, Haas AR, Gonzalez HX, Springmeyer SC; IBV Valve US Pilot Trial Research Team: A multicenter pilot study of a bronchial valve for the treatment of severe emphysema. Respiration 2010; 79: 222-233.
56. Gulsen A, Sever F, Girgin P, Tamci NB, Yilmaz H: Evaluation of bronchoscopic lung volume reduction coil treatment results in patients with severe emphysema. Clin Respir J 2015, Epub ahead of print.
57. Kontogianni K, Gerovasili V, Gompelmann D, Schuhmann M, Heussel CP, Herth FJ, Eberhardt R: Effectiveness of endobronchial coil treatment for lung volume reduction in patients with severe heterogeneous emphysema and bilateral incomplete fissures: A six-month follow-up. Respiration 2014; 88: 52-60.
58. Herth FJF, Valipour A, Shah P, et al: STEP-UP randomized controlled trial of segmental vapor ablation in patients with severe emphysema: month results. Lancet Respir Med 2016, accepted.